Changes in Antithrombin Activity and Platelet Counts in the Late Stage of Twin and Triplet Pregnancies

ABSTRACT

It is possible that women with triplet pregnancies are more likely to exhibit pregnancy-induced antithrombin deficiency, gestational thrombocytopenia, and perinatal elevation in serum aspartate aminotransferase (AST) than women with twin pregnancies. We retrospectively reviewed changes in antithrombin activity, platelet count, and blood chemistry in 23 twin and seven triplet pregnancies in which the mothers received antenatal care and gave birth in our hospital during 1999 and 2001. Both antithrombin activity and platelet counts gradually decreased until delivery, then promptly increased after delivery in both twin and triplet pregnancies. A significantly larger number of women developed gestational thrombocytopenia of < 100 × 10⁹/L (43% [three of seven] versus 4.3% [one of 23]; p < 0.01) and pregnancy-induced antithrombin deficiency of < 60% of normal activity (57% [four of seven] versus 17% [four of 23]; p < 0.05) in triplet than in twin pregnancies. Eight women with pregnancy-induced antithrombin deficiency, including three women with gestational thrombocytopenia, were significantly more likely to develop perinatal elevations of AST, lactate dehydrogenase, serum creatinine, fibrin/fibrinogen degradation products, and D-dimer than were those without pregnancy-induced antithrombin deficiency. These findings suggest that women with triplet pregnancies are at an increased risk of the HELLP syndrome and acute fatty liver of pregnancy compared with women with twin pregnancies.

KEYWORDS

Acute fatty liver of pregnancy - HELLP syndrome - pregnancy-induced antithrombin deficiency - thrombocytopenia

REFERENCES

• 1 Abildgard U. Review of antithrombin III. Evidence that antithrombin III is the main physiological inhibitor of coagulation enzymes. In: Collen D, Wiman B, Verstraete M The Physiological Inhibitor of Blood Coagulation and Fibrinolysis Amsterdam; Elsevier, North Holland Biomedical Press 1979: 19-34
• 2 Minakami H, Kimura K, Tamada T, Matsuda A, Kobayashi S, Matsumoto S. Acute fatty liver of pregnancy: case report with literature review.  Nippon Sanka Fujinnka Gakkai Zasshi. 1982;  34 637-640
• 3 Castro M A, Goodwin T M, Shaw K J, Ouzounian J G, McGehee W G. Disseminated intravascular coagulation and antithrombin III depression in acute fatty liver of pregnancy.  Am J Obstet Gynecol. 1996;  174 211-216
• 4 Minakami H, Watanabe T, Izumi A et al.. Association of a decrease in antithrombin III activity with a perinatal elevation in aspartate aminotransferase in women with twin pregnancies: relevance to the HELLP syndrome.  J Hepatol. 1999;  30 603-611
• 5 Tsunoda T, Ohkuchi A, Izumi A et al.. Antithrombin III activity and platelet count are more likely to decrease in twin pregnancies than in singleton pregnancies.  Acta Obstet Gynecol Scand. 2002;  81 840-845
• 6 Riely C A. Acute fatty liver of pregnancy.  Semin Liver Dis. 1987;  7 47-54
• 7 Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy.  Am J Obstet Gynecol. 1982;  142 159-167
• 8 Al-Kouatly H B, Chasen S T, Kalish R B, Chervenak F A. Causes of thrombocytopenia in triplet gestations.  Am J Obstet Gynecol. 2003;  189 177-180
• 9 Malone F D, Kaufman G E, Chelmow D, Athanassiou A, Nores J A, D'Alton M E. Maternal morbidity associated with triplet pregnancy.  Am J Perinatol. 1998;  15 73-77
• 10 Minakami H, Kohmura Y, Izumi A, Watanabe T, Matsubara S, Sato I. Relation between gestational thrombocytopenia and the HELLP syndrome.  Gynecol Obstet Invest. 1998;  46 41-45
• 11 Sheehan H L. The pathology of acute yellow atrophy and delayed chloroform poisoning.  J Obstet Gynaecol Br Emp. 1940;  47 49-61
• 12 Rolfes D B, Ishak K G. Acute fatty liver of pregnancy: a clinico-pathologic study of 35 cases.  Hepatology. 1985;  5 1149-1158
• 13 Minakami H, Oka N, Sato T, Tamada T, Yasuda Y, Hirota N. Pre-eclampsia: a microvesicular fat disease of the liver?.  Am J Obstet Gynecol. 1988;  159 1043-1047
• 14 Minakami H, Takahashi T, Tamada T. Should routine liver biopsy be done for the definite diagnosis of acute fatty liver of pregnancy?.  Am J Obstet Gynecol. 1991;  164 1690-1691
• 15 Sibai B M, Taslimi M M, El-Nazer A et al.. Maternal-perinatal outcome associated with the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia-eclampsia.  Am J Obstet Gynecol. 1986;  155 501-509
• 16 Martin Jr J N, Rinehart B K, May W L, Magann E F, Terrone D A, Blake P G. The spectrum of severe preeclampsia: comparative analysis by HELLP syndrome classification.  Am J Obstet Gynecol. 1999;  180 1373-1384
• 17 Martin Jr J N, Blake P G, Perry Jr K G et al.. The natural history of HELLP syndrome: patterns of disease progression and regression.  Am J Obstet Gynecol. 1991;  164 1500-1513
• 18 Freedman J, Musclow E, Garvey B, Abbott D. Unexplained periparturient thrombocytopenia.  Am J Hematol. 1986;  21 397-407
• 19 Burrows R F, Kelton J G. Fetal thrombocytopenia and its relation to maternal thrombocytopenia.  N Engl J Med. 1993;  329 1463-1466
• 20 Minakami H, Kuwata T, Sato I. Gestational thrombocytopenia: is it new?.  Am J Obstet Gynecol. 1996;  175 1676-1677